Børsen
A number of Novo investors see the pharmaceutical giant’s lawsuit against Eli Lilly as a sign of a more offensive approach to the battle for the weight loss market.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?